B

Biocartis Group NV
BCART

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€27.24M
EV
-
Shares Outstanding
93.92M
Beta
1.10

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E 2023E
-
P/Revenue 2023E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Biocartis Group NV

gainify

B

Biocartis Group NV

BCART

Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. Its proprietary molecular diagnostics Idylla platform is a...

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Moody, Roger

Employees

526

IPO Date

2015-04-27

Headquarters

Generaal de Wittelaan 11 B, Mechelen, Antwerp, 2800, Belgium

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.